Skip to main content

It’s been a strong year following HGL Private Capital’s investment in FutureMeds, as they continue to accelerate their growth plans, having significantly grown both organically and through acquisitions.

Ged Gould, Founding Director of HGL Private Capital commented “FutureMeds are fast becoming one of Europe’s leading independent Site Management Organisations. It’s been a great year for the team at FutureMeds, their patients and clients, as they continue to grow at a rapid rate and explore new acquisitions.  Highlights include 3 more sites being acquired, 45+ studies started, expansion from 2 sites in 1 country to 12 sites in 4 countries, to 1500+ patients joined and much more!”

“We look forward to continuing to support the team at FutureMeds with their exciting growth plans and delivering significant shareholder value throughout their journey.”

Recent FutureMeds success stories:

 

Can HGL Private Capital help to turbocharge your growth plans? Get in touch with our team today.

Leave a Reply